EP2026832
Samsetning af interferón-beta og klaribín meðferðaráformum til meðhöndlunar á heila- og mænusiggi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
23.5.2007EP published:
2.5.2012EP application number:
07729448.6
EP translation filed:
12.6.2012Grant published:
15.7.2012EPO information:
European Patent Register
Max expiry date:
22.5.2027Expiry date:
22.5.2015
Title:
COMBINATION OF INTERFERON-BETA AND A CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
Timeline
Today
23.5.2007EP application
2.5.2012EP Publication
12.6.2012Translation submitted
15.7.2012Registration published
22.5.2015Expires
Owner
Name:
Merck Serono SAAddress:
Centre Industriel, 1267, Coinsins, Vaud, CH
Inventor
Name:
BRENTZEL, H., James, Jr.Address:
Marshfield, MA, US
Name:
LOPEZ-BRESNAHAN, MariaAddress:
Lincoln, MA, US
Name:
AMMOURY, NazihAddress:
Prévessin-Moëns, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
06114537Date:
24.5.2006Country:
EP
Number:
845470 PDate:
18.9.2006Country:
US
Classification
Categories:
A61K 38/21, A61K 9/00, A61K 31/7056, A61P 37/06
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 2.6.2012
Expires: 22.5.2013
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 9.4.2013
Expires: 22.5.2014
Payer: Árnason Faktor
Number: 8
Paid: 9.4.2014
Expires: 22.5.2015
Payer: Árnason Faktor